Related Experiment Videos

[Calcium antagonists in the treatment of heart diseases]

Schweizerische Medizinische Wochenschrift
|May 8, 1982
PubMed

Insights

Calcium antagonists reduce transmembrane calcium flow, benefiting cardiac conditions. They offer antianginal, antiarrhythmic, antihypertensive, and cardioprotective effects, crucial for treating arrhythmias and vasospasms.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Calcium antagonists are vital in managing cardiac diseases.
  • Their primary mechanism involves reducing transmembrane calcium conductivity.

Purpose:

  • To elucidate the pharmacological effects and clinical applications of calcium antagonists.
  • To highlight their role in treating various cardiovascular conditions.

Summary:

  • Calcium antagonists decrease myocardial oxygen consumption and metabolism.
  • They depress pacemaker activity and AV-node conduction while suppressing ectopic beats.
  • Vascular smooth muscle tone is reduced, and arterial spasms are inhibited.

Impact:

  • Clinical uses include antianginal, antiarrhythmic, antihypertensive, and cardioprotective effects.
  • Currently used for supraventricular tachyarrhythmias and coronary vasospasms.
  • Potential new applications include hypertrophic cardiomyopathy and myocardial protection during ischemia.

Related Concept Videos